Sensei Biotherapeutics Inc (SNSE)
0.47
+0.02
(+3.50%)
USD |
NASDAQ |
Dec 26, 12:35
Sensei Biotherapeutics Enterprise Value: -35.58M for Dec. 24, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Relmada Therapeutics Inc | -43.21M |
| Genprex Inc | 6.409M |
| Ensysce Biosciences Inc | 8.928M |
| IN8bio Inc | 13.00M |
| NovaBay Pharmaceuticals Inc | 1.919M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.253M |
| Total Expenses (Quarterly) | 7.823M |
| EPS Diluted (Quarterly) | -0.29 |
| Earnings Yield | -253.2% |